Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge

Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge

Abstract Dyspnea is a prominent symptom in patients with long COVID due to its high prevalence and significant clinical impact. However, the influence of commonly used medications in critically ill patients on long-term dyspnea remains unclear. This study aimed to identify risk factors and assess th...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlos Toufen, Gustavo Corrêa de Almeida, José Eduardo Pompeu, Celso Ricardo Fernandes de Carvalho, Carlos Roberto Ribeiro de Carvalho
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
ARDS
Neuroleptics
COVID-19
Long Covid
Dyspnea
Online Access:https://doi.org/10.1038/s41598-025-91010-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items